Clinical Trial Update: Effect of Eplerenone on Endothelial Function in Metabolic Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effect of eplerenone on endothelial function in metabolic syndrome has completed; results are not provided in the available data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Metabolic Syndrome

Drugs mentioned

• Inspra (eplerenone)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Metabolic Syndrome, Endothelial Dysfunction | Phase 3 | Status: COMPLETED